Pharmaceutical formulation for topical administration comprising b220

• 收藏
• 分享

专利权人:

VIRONOVA AB

发明人:

HOMMAN MOHAMMED,BERGMAN JAN

申请号：

NZ61331312

公开号：

NZ613313A

申请日:

2012.02.17

申请国别(地区):

NZ

年份:

2015

代理人:

摘要：

Disclosed herein is the use of 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline (B-220) or a pharmaceutically acceptable salt for the manufacturing of a medicament for use in the treatment of herpes virus infections of the skin or mucous membranes in a mammalian subject by topical administration of a therapeutically effective dose of said medicament to the skin or mucous membrane of the mammalian subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/